Xonefit-T 281.25 Injection
Marketer
Medizia Biotech
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Xonefit-T 281.25 Injection
Xonefit-T 281.25 Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, thus curbing infection spread. Administration must be overseen by a medical professional. Consistent adherence to the prescribed schedule is crucial; completing the entire course is vital, even with symptom improvement. Premature cessation may compromise efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical consultation. Allergic reactions (rash, pruritus, edema, dyspnea) demand prompt medical attention. Prior to commencing treatment, disclose all medications and health conditions to your physician. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential additive drowsiness. While typically non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and hydration are beneficial for recovery. Your doctor may order tests to monitor the medication's impact.
Primary Ingredients of Xonefit-T 281.25 Injection
No text provided. Please provide the text you want me to rephrase.
Uses of Xonefit-T 281.25 Injection
Infections caused by bacteria
Major Benefits of Xonefit-T 281.25 Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Xonefit-T 281.25 Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Xonefit-T 281.25 Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Xonefit-T 281.25 Injection works:
Xonefit-T 281.25 Injection merges Ceftriaxone, a bacterium-fighting antibiotic, with Tazobactum, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactum counteracts bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Xonefit-T 281.25 Injection.
PregnancySAFE IF PRESCRIBED
Xonefit-T 281.25 Injection is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human studies are scarce.
Breast feedingCAUTION
Administration of Xonefit-T 281.25 Injection necessitates prudence while breastfeeding. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Xonefit-T 281.25 Injection can potentially reduce attentiveness, impair visual acuity, and induce drowsiness or vertigo. Driving should be avoided if any of these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the use of Xonefit-T 281.25 Injection in individuals with renal impairment is scarce. Seek medical advice from your physician.
LiverCAUTION
Administering Xonefit-T 281.25 Injection requires careful consideration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Xonefit-T 281.25 Injection is not suggested for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Xonefit-T 281.25 Injection :
Should you inadvertently omit a scheduled dose of Xonefit-T 281.25 Injection, seek immediate medical advice.
Facts to Know About Xonefit-T 281.25 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Anti-infective Agents |
3,018 People bought this recently